Levita Magnetics has reached a landmark achievement with the successful completion of over 1,000 surgeries using its FDA-cleared MARS® (Magnetic-Assisted Robotic Surgery) System—a significant milestone underscoring the system’s growing role in advancing minimally invasive surgical care. The 1,000th procedure, a gastric bypass performed at Stanford Health Care by Dr. Brian Ruhle, highlights how MARS is being adopted by leading institutions to optimize surgical visualization and precision without additional incisions. Powered by Dynamic Magnetic Positioning™ technology, the MARS System is the only platform that enables magnetic retraction of organs and tissue, reducing invasiveness while supporting high-quality surgical outcomes.

This innovation is reshaping operative workflows across a broad spectrum of procedures—including bariatric, colorectal, prostatectomy, and hiatal hernia repair—by enhancing visibility, improving ergonomics, and reducing patient trauma. Surgeons report faster recoveries, less post-operative pain, and superior cosmetic outcomes thanks to the system’s ability to eliminate ports and retract organs without rigid instruments. The device’s compatibility with robotic platforms and augmented reality systems further extends its utility, reinforcing its role as a versatile, surgeon-centric solution in both public and private healthcare settings.

Looking ahead, Levita Magnetics is well-positioned to scale its impact globally, following expanded FDA clearances and clinical adoption in Chile, the U.S., and beyond. With increased interest from ambulatory surgery centers and broader application across complex cases, the MARS System is paving the way for a new standard in less invasive, cost-effective surgical care. As the company continues to collaborate with forward-thinking surgical teams, its magnetic-assisted platform is expected to unlock new frontiers in digital, robotic, and precision-guided surgery.